View Press Releases
-
DxCG Intelligence Celebrates 25th Anniversary, Launches Version 6.0 with Enhanced Clinical and Pharmaceutical Classification Systems
Cotiviti’s preeminent risk assessment and predictive modeling tool continues to aid in improving healthcare cost and quality
Jan 24, 2022
-
Protecting All Assets from All Cyber Attacks Is Unrealistic; Focus on Preventing the Unacceptable: Positive Technologies CEO
In a talk at the World Expo 2020 Dubai on Sunday, Positive Technologies CEO, Denis Baranov spoke about how protecting all assets from all cyberattacks is unrealistic, and suggested that organizations and industries instead take a new approach that specifically focuses on eliminating ‘unacceptable’ risks at every level.
Jan 24, 2022
-
CD ComputaBio Unveils Ligand-based Pharmacophore Model Service for Drug Design and Screening
CD ComputaBio, a reliable computational biology service provider located in New York, is always hammering away at research and trials in order to provide customers with access to the latest software, technologies, and expertise at a competitive price and fast turnaround time. The company recently announced the launch of ligand-based pharmacophore model service for scientists to accelerate the drug candidate development process.
Jan 23, 2022
-
Creative Proteomics Lipidomics Launches Exosomes Lipidomics Service to Study the Biological Characteristics of Vesicles
Lipidomics, a division of Creative Proteomics, is committed to providing untargeted lipidomics services, targeted lipidomics services, metabolic flux analysis services, and lipidomics related services for research institutions, biotechnology and pharmaceutical companies. The company continues to accelerate lipidomics research to make contributions in the fields of biopharmaceuticals, population health, the food industry, etc. Creative Proteomics Lipidomics has recently announced the launch of Exosomes Lipidomics Service, which can help scientists understand vesicle biogenesis and function, identify lipid-based biomarkers and unravel their monitoring function in diseases.
Jan 25, 2022
-
GutFlora Omics Platform Launches Virome Sequencing Service to Investigate Gut Microbiota
-
Creative Proteomics Cytokine Unveils Disease Cytokine Assays for Disease Diagnosis
Cytokine division belongs to Creative Proteomics, which specializes in providing cytokine research and analysis services for researchers in the pharmaceutical and biotechnology industries, as well as academic institutes and government agencies. Creative Proteomics Cytokine recently announced Disease Cytokine Assays to help researchers obtain higher quality scientific research data.
Jan 12, 2022
-
Amerigo Scientific Launches Polycaprolactone for Bioprinting
Amerigo Scientific introduces Polycaprolactone for research uses.
Jan 25, 2022
-
STEMart Introduces Chemical Characterization for Medical Device Industry
STEMart launches chemical characterization services for the medical device industry.
Jan 25, 2022
-
Queen’s University Belfast enters collaboration and licensing agreement with Ipsen to progress FLIP inhibitor project which has been supported by Domainex
Domainex Ltd., a leading provider of integrated drug discovery services to life science organisations globally, is delighted that Professors Daniel Longley, Tim Harrison and colleagues at Queen’s University Belfast have entered into a collaboration and licensing agreement with Ipsen. The agreement provides an exclusive licence to research, develop, manufacture and commercialise FLIP inhibitors. Domainex has supported the FLIP inhibitor programme from its inception.
Jan 25, 2022
-
Positive Technologies Names Top 10 Phishing Topics of 2021
Positive Technologies today issued a new study that outlines the top 10 phishing topics used by cybercriminals throughout 2021, including: • New TV shows and movies • Banking issues • Travel and vacation • Dating • And cryptocurrency investments
Jan 25, 2022
-
Samsung Biologics reaches agreement with Biogen to acquire full ownership of Samsung Bioepis
-
Sharp invests in new gene therapy packaging and distribution capacity at EU Heerenveen facility
-
Rousselot Announces Partnership with Terasaki Institute for Biomedical Innovation
Rousselot®, Darling Ingredients’ health brand and the world’s leader of collagen-based solutions, today announced that it has partnered with the Terasaki Institute for Biomedical Innovation (TIBI), a California-based research institute focused on regenerative medicine.
Jan 11, 2022
-
Curebase and Persephone Biosciences Partner in Clinical Trial of Colorectal Cancer Among Diverse Populations
Curebase and Persephone Biosciences Partner in Clinical Trial of Colorectal Cancer Among Diverse Populations
Jan 10, 2022
-
PubHive Helps Safety & Vigilance Teams Harness Signal Workflows
PubHive Navigator SaaS platform now supports life science companies with workflow and information management needs across literature, aggregate reporting, and safety signal detection.
Jan 10, 2022
-
Pharmaron acquires commercial API manufacturing facility in the United Kingdom from Recipharm
Pharmaron Beijing Co., Limited, has announced today that it has acquired Aesica Pharmaceuticals Limited ("The Cramlington Site") from Recipharm group. This move will again help Recipharm streamline operations in line with its strategic goals and better align with customers' needs.
Jan 10, 2022
-
Recipharm announces sale of Fontaine-lès-Dijon site to Astrea
Recipharm has today announced the sale of the solid dose manufacturing site at Fontaine-lès-Dijon, France, to Astrea Pharma. The move is a positive step in streamlining Recipharm's operations and consolidating its position as a top five global Contract Development and Manufacturing Organisation.
Jan 9, 2022
-
PubHive Optimizes End-to-End Aggregate Safety Reporting Workflows
PubHive Navigator expands safety and vigilance module, adding one-stop workflow and information management capabilities for aggregate reporting and authoring.
Jan 8, 2022
-
Watson-Marlow enhances strong European connections providing further international support for Flexicon Liquid Filling
Watson-Marlow Fluid-Technology Group (WMFTG) is pleased to confirm that it will be providing the sales and technical support for Flexicon in both Poland and the Czech Republic from January 2022.
Jan 11, 2022
-
Atlantic Health System Takes Consumer Convenience to the Next Level with Online Scheduling from Kyruus
New Jersey-Based Health System Sees Increase in Online Appointment Bookings
Jan 11, 2022